PATENT CLAIM ANALYSIS

Application Number: 16323863
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["544", "242000"]

Abstract:
Provided is a heterocyclic compound that may have a GCN2 inhibitory action, and is expected to be useful for the prophylaxis or treatment of GCN2 associated diseases including cancer and the like. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

Claim (Index 14):
The compound according to  claim 1  or a salt thereof which is used for the prophylaxis or treatment of cancer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.28261
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14404126', '14902388', '15467548', '15563161', '13566091']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8061171310241627
- 35 USC 102 Novelty (BERT): 0.5180894456778711
- Combined Prediction Score: 0.7773143624895336
- Mean Citation Score: 316.363878
- Max Citation Score: 319.5668
- Similarity Product: 220.84825399124625

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test